Revenue, Losses Down for Jones Soda in First Quarter

May 4, 2023 · Green Market Report

The company is looking to its THC-infused beverages, Mary Jones, for growth momentum.

Jones Soda Co. (CSE: JSDA) (OTCQB: JSDA) had a tougher first quarter than in 2022, with revenues down by 13%, but the company also managed to decrease its rate of losses by 17% from the first quarter a year ago.

According to its first quarter 2023 earnings report, Jones Soda pulled in $3.9 million for the first three months of the year, compared to $4.5 million for the same timeframe in 2022. It also posted a $1.4 million loss, an improvement from the $1.7 million loss in Q1 2022.

The company attributed the decrease in losses to an “increase in gross profit margin and a decrease in total operating expenses,” and said the disappointing comparison was due to an “outsized sales performance” in Q1 2022.

As of March 31, Jones Soda had $6.4 million in the bank, down from $8 million at the close of 2022.

CEO Mark Murray said he knew heading into 2023 that the first quarter would be “challenging” just by comparison to the 2022 revenues, but said he believes the company has momentum going forward, in part thanks to its line of THC-infused beverages, Mary Jones.

“Momentum continues to grow in California, where we have seen strong sales of our 10-milligram and 100-milligram beverages,” Murray said in a press release.

“In response to this strong performance, we are planning to expand our flavor portfolio with the addition of grape and cola, bringing the lineup to a total of six great tasting options,” Murray added. “Outside of California, we are gaining traction and are on track with planned expansions in Washington, Michigan, and Nevada.”

Murray also said there have been promising developments in Jones Soda’s noninfused beverage business relationships with big vendors such as Target, Meijer, and and Kroger, which overall has the company on a solid path forward.

“Despite inflationary pressures in the consumer environment and some persistent supply chain uncertainties, we are pleased to be making steady progress, which we believe will further position Jones Soda for long-term success,” Murray said. (Full Story)

In category:Drinks
Tags:
Next Post

What is Pre-Milled Cannabis Flower and Can You Smoke It? (Is It Good?)

Ever Seen Pre-Milled Cannabis Flower At Your Local Dispensary?What It Is, And How You Can Use It When we think of buying cannabis at a dispensary, we imagine walking into an aromatic shop filled with many different types of beautiful cannabis…
Read
Previous Post

Making cannabis edibles at home? Try these delicious thumbprint cookies and other recipes

The modern cannabis edible has changed significantly since the birth of the classic pot brownie. In today’s world, there are gourmet cannabis chefs, edible dining courses, infused dinner parties and a plethora of brands selling sophisticated edibles at dispensaries. All…
Read
Random Post

SIBLINGS SENTENCED IN PLOT TO BRIBE CALIFORNIA SHERIFF IN MARIJUANA GROW CASE

A brother-and-sister team convicted of trying to bribe a Northern California sheriff to protect family marijuana grows were sentenced Tuesday in Sacramento, but there were stark differences in the punishment each received. Gaosheng Laitinen, 41, a small shop owner in…
Read
Random Post

Marijuana advertisers face hurdles with Twitter’s newest ad policies

Twitter might have further eased its rules for cannabis advertising, but the changes don’t seem to have made it any easier for marijuana businesses to take advantage of the social media platform’s wide reach. Regulatory red tape, Twitter’s unfamiliarity with…
Read
Random Post

New Mexico’s medical cannabis program by the numbers

A recent report sheds some light on how many people are taking part in New Mexico’s medical cannabis program, which helps patients with a wide range of conditions. The latest numbers, from May 2023, show there are more than 100,000 patients enrolled in the…
Read
Random Post

Zappy Zapolin's Psycheceutical Files Patent, Hopes Ketamine Topical Can Treat PTSD

Lifesciences biotech company Psycheceutical Bioscience  BWVI, of which Benzinga’s advisory council member Zappy Zapolin is Chief Visionary Officer, patented a topical ketamine formulation to treat PTSD. The patent includes related methods using drug delivery technology NeuroDirect. Psycheceutical CEO Chad Harman says NeuroDirect’s topical delivery system…
Read